HR5275-119

In Committee

Diagnostic Accuracy in Sepsis Act of 2025

119th Congress Introduced Sep 10, 2025

Summary

What This Bill Does

The Diagnostic Accuracy in Sepsis Act makes blood culture contamination a Medicare hospital-acquired condition for subsection (d) hospitals beginning with fiscal year 2026 discharges. The bill amends the Social Security Act hospital-acquired condition reduction program so blood culture contamination is included alongside existing hospital-acquired conditions. It directs the HHS Secretary, when establishing a blood culture contamination measure for determining whether a hospital is an applicable hospital under the program, to set the measure on the basis that the contamination rate should not exceed 1 percent. The practical effect is to put hospitals' blood-culture contamination rates into Medicare quality and payment accountability, which matters for sepsis diagnosis because contaminated cultures can trigger misdiagnosis, unnecessary antibiotics, longer stays, and avoidable costs.

Who Benefits and How

Medicare patients benefit because hospitals have a stronger incentive to reduce contaminated blood cultures that can distort sepsis diagnosis. Clinical laboratory quality teams benefit from a clear federal benchmark that contamination rates should not exceed 1 percent. Patient safety organizations benefit because blood culture contamination becomes part of Medicare hospital-acquired condition accountability. Hospitals with strong blood-culture practices benefit competitively if lower contamination helps avoid Medicare penalties.

Who Bears the Burden and How

Subsection (d) hospitals must track and reduce blood culture contamination to avoid hospital-acquired condition penalties. Hospital laboratory staff must strengthen collection protocols, contamination monitoring, and quality-control processes. Centers for Medicare and Medicaid Services staff must establish and administer the blood culture contamination measure. Hospitals with contamination rates above 1 percent face greater Medicare payment risk.

Key Provisions

  • Adds blood culture contamination to Medicare hospital-acquired conditions for fiscal year 2026 and later discharges.
  • Requires the Secretary to establish a blood culture contamination measure for subsection (d) hospitals.
  • Limits the measure around a contamination rate that should not exceed 1 percent.
  • Strengthens Medicare quality accountability for sepsis-related diagnostic accuracy.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Adds blood culture contamination to Medicare's hospital-acquired condition reduction program for fiscal year 2026 and later discharges and directs HHS to set the contamination measure at a rate not exceeding 1 percent.

Key Policy Areas

Medicare, Hospitals, Patient Safety

Primary Purpose

Adds blood culture contamination to Medicare's hospital-acquired condition reduction program for fiscal year 2026 and later discharges and directs HHS to set the contamination measure at a rate not exceeding 1 percent.

Policy Domains

Medicare Hospitals Patient Safety

Resolution provisions

Identified Gains
  • Medicare patients
  • Clinical laboratory quality teams
  • Patient safety organizations
  • Hospitals with strong blood-culture practices
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Medicare patients:
Patient safety organizations:
Clinical laboratory quality teams:
Hospitals with strong blood-culture practices:
Identified Costs
  • Subsection (d) hospitals
  • Hospital laboratory staff
  • Centers for Medicare and Medicaid Services staff
  • Hospitals with contamination rates above 1 percent
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Subsection (d) hospitals:
Hospital laboratory staff:
Centers for Medicare and Medicaid Services staff:
Hospitals with contamination rates above 1 percent:

Legislative Progress

In Committee
Introduced Committee Passed
Sep 10, 2025

Mr. Kelly of Pennsylvania (for himself and Ms. Craig) introduced …

Sep 10, 2025

Referred to the House Committee on Ways and Means.

Sep 10, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Clinical Laboratories
2 mentions across 1 clause
+1 positive -1 negative

Clinical laboratory quality teams, Hospital laboratory staff

Positive-direction: Clinical laboratory quality teams

Negative-direction: Hospital laboratory staff

Healthcare Beneficiaries
1 mention across 1 clause
+1 positive

Medicare patients

Health Care
1 mention across 1 clause
+1 positive

Patient safety organizations

Healthcare
1 mention across 1 clause
-1 negative

Subsection (d) hospitals

Government
1 mention across 1 clause
-1 negative

Centers for Medicare and Medicaid Services staff

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Medicare Hospitals Patient Safety

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology